Saving Seafood

Court orders FDA to assess environmental impact of GM salmon

November 6, 2020 — A federal court judge ordered the U.S. Food and Drug Administration on Thursday to conduct an environmental assessment of genetically modified salmon that he said was required for the agency’s approval of the fish.

But the judge did not vacate the FDA’s approval of the salmon for human consumption in the meantime, because he said the risk for near-term environmental harm is low.

“The FDA has to go back to the drawing board and do its homework,” said George Kimbrell, legal director for the Center for Food Safety, one of the groups that filed suit challenging the agency’s approval of the genetically modified salmon.

The ruling by U.S. District Court Judge Vince Chhabria in San Francisco centers on AquaBounty’s salmon, which are genetically modified to grow faster than normal salmon. In 2015, the fish became the first genetically modified animal approved for human consumption in the U.S. After clearing other regulatory hurdles. AquaBounty began growing the fish in indoor tanks at an Indiana plant last year.

Read the full story at The Washington Post

ALASKA: Sealaska subsidiary’s mislabeled halibut recalled by FDA

October 30, 2020 — A labeling mistake has led the FDA to order the recall of more than two tons of packaged halibut filets produced by a subsidiary of Sealaska, the Juneau-based Alaska Native regional corporation.

The agency initiated the recall on October 23 after it was discovered that the breaded filets — advertised as gluten free — contain wheat and milk but did not reveal the presence of the potential allergens. No illnesses have been reported.

The fish was supplied and packaged by Orca Bay Foods. Since 2017 the Seattle area-based processor has been wholly owned by Sealaska, whose Alaska Native shareholders live in Southeast Alaska and the greater Pacific Northwest.

Read the full story at Raven Radio

National Fisheries Institute Statement on the FDA’s Smarter Food Safety Blueprint

July 14, 2020 — The following was released by the National Fisheries Institute:

Yesterday’s announcement of the Food and Drug Administration’s (FDA) New Era of Smarter Food Safety blueprint demonstrates how the agency plans to rapidly evolve its regulatory approach in an age of unprecedented technological advancement.

Forecasting unique demands on the future value chain will help FDA identify and whenever possible neutralize challenges. In just the past few months, the seafood market has changed and the seafood community and FDA have worked to keep our food supply safe with a rigorous yet flexible approach.

We are pleased to see the Trump Administration embracing a food safety framework for the future that is both smart and safe.

The Facts About Seafood, COVID, and Chinese Food Markets

June 17, 2020 — The following was released by the National Fisheries Institute:

On 13 June, Chinese media began reporting on the closure of the Xinfadi food markets in Beijing due the presence of COVID-19.

Do not be misled by sensational reports.  The facts are clear.  And these are the facts about food according to academic experts and global public health officials and agencies:

Former Commissioner of US Food and Drug Administration states:  “The idea it hitched a ride on fish is highly implausible.  I mean it is absurd.  I can’t see any plausible scenario where this virus rode in on a salmon.”

The World Health Organization states:  “As food has not been implicated in the transmission of COVID-19, testing of food or food surfaces for this virus is not recommended.”

The Codex Alimentarius states:  “COVID-19 is a respiratory illness primarily transmitted through person-to-person contact and direct contact with respiratory droplets generated when an infected person coughs or sneezes.  There is no evidence to date of viruses that cause respiratory illnesses being transmitted via food or food packaging.  Coronaviruses cannot multiply in food; they need an animal or human host to multiply. It is highly unlikely that people can contract COVID-19 from food or food packaging.”

The Food and Agriculture Organization of the United Nations states: “Despite the hypothesis that the virus may have originated in bats and infected another animal used for food, there is no evidence of continued transmission of the virus from animals to humans through the food chain.”

The US Food and Drug Administration states: “…. there is no evidence that food or food packaging have been associated with transmission (of COVID-19) and no reason to be concerned.”

The US Centers for Disease Control and Prevention states:  “In general, because of poor survivability of these coronaviruses on surfaces, there is likely very low risk of spread from food products or packaging..”

Canadian Food Inspection Agency states:  “Scientists and food safety authorities around the world are closely monitoring the spread of COVID-19.  There are currently no reported cases of COVID-19 being spread through food.”

The Norwegian Food Safety Agency states:  “There are no known cases of infection via contaminated food, imported food or water.  Therefore, fish and seafood products from Norway are safe to eat” and “Currently there are no known cases of infection via contaminated food, imported food or water.  Based on current knowledge of coronaviruses, infection via food and water is considered unlikely.”

The European Food Safety Authority states:  “Experiences from previous outbreaks of related coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), show that transmission through food consumption did not occur.  At the moment, there is no evidence to suggest that coronavirus is any different in this respect.”

The German Federal Institute for Risk Assessment states: “There are currently no cases which have shown evidence of humans being infected with the new type of coronavirus via the consumption of contaminated food.  There is also currently no reliable evidence of transmission of the virus via contact with contaminated objects or contaminated surfaces, which would have led to subsequent human infections.”

The Chilean National Fisheries and Aquaculture Service states:  “There is no evidence to suggest that SARS-CoV-2 can infect aquatic animals and, therefore, these animals do not play an epidemiological role in spreading COVID-19 to humans.”

University College London researchers state:  “SARS-CoV-2 can infect a broad range of mammals, but few fish, birds or reptiles” and that “most [fish] have no susceptibility to infection.”

Asian Fisheries Science journal states:  “Currently, there is no evidence to suggest that SARS-CoV-2 can infect aquatic food animals (e.g. finfish, crustaceans, molluscs, amphibians) and therefore these animals do not play an epidemiological role in spreading COVID-19 to humans.”  (authors include 16 global public health researchers)

North Carolina State University researcher states:   “In fact, we don’t see evidence of any respiratory viruses being transmitted through food in the past.”  (COVID-19 is a respiratory virus) and “‘The good news with this particular virus is that it is not a foodborne virus.  Most of the food that we eat, ends up getting right into our gut and ends up encountering a whole bunch of acid in our stomachs.  And this virus particularly doesn’t really remain infectious once it hits the stomach.”

For more information about what global public health professionals say about seafood and COVID, visitCOVID-19 & Seafood website.

For Your Heart, Eat Fish Or Take Pills? Now There’s A Drug Equal To 8 Salmon Servings

November 25, 2019 — It’s long been known that eating fish — especially cold-water fish such as salmon that are rich in omega-3 fatty acids — is good for heart health.

But, for the millions of Americans who are at high risk of heart disease, eating enough fish to make a difference isn’t likely to be realistic for most.

There’s growing evidence that taking a very high dose of purified fish oil, delivered in a prescription pill, can help prevent heart attacks and strokes among people who have elevated risks. The amount of fish oil in the daily recommended dose of the pill is the equivalent of eating about eight to 10 servings of salmon a day.

In early November, an advisory panel to the FDA voted unanimously to approve expanded use of the prescription drug, Vascepa, which is made from one type of omega-3 fatty acid, called eicosapentaenoic acid, or EPA for short. The oil is extracted from sardines and anchovies, and then purified.

Currently, Vascepa is already approved for use in people with very high levels of triglycerides — which is a type of fat in the blood. (You can check your triglycerides as part of a cholesterol screening.)

Read the full story at NPR

US lieutenant governors call for more inspections on imported seafood

July 24, 2019 — Lieutenant governors in the United States have put their weight behind a resolution sponsored by Lt. Governor Billy Nungesser (R-Louisiana) calling for additional inspections of imported seafood.

The resolution was approved at the National Lieutenant Governors Association annual meeting, which took place last week in Wilmington, Delaware. It calls on the U.S. Food and Drug Administration and the U.S. Department of Agriculture to “take immediate measures” to inspect foreign seafood, both at the point of harvest and when it enters the country.

Nungesser’s resolution was supported by Lt. Governor Susan Bysiewicz (D–Connecticut), Lt. Governor Bethany Hall-Long (D–Delaware), Lt. Governor Kate Marshall (D–Nevada) and Lt. Governor Kevin Meyer (R–Alaska).

The resolution calls on the creation of an inspection fee in the range of USD 0.05 (EUR 0.04) to USD 0.10 (EUR 0.09) per pound. Seafood caught by American fishermen and sent overseas for processing would be exempt from the inspection process.

Read the full story at Seafood Source

Groups praise updated US government seafood guidance

July 9, 2019 — U.S. seafood groups are lauding an updated government guidance that encourages pregnant and breastfeeding women and children to eat more seafood.

The U.S. Food and Drug Administration is updating its 2015-2020 Dietary Guidelines for Americans, released in 2017, which recommends that Americans eat at least eight ounces of seafood per week, based on a 2,000-calorie diet. While FDA did not increase the amount of seafood adults should eat, it is emphasizing the nutritional benefits – particularly to pregnant and breastfeeding women as well as children – of eating at least eight ounces of seafood weekly.

The agency also aims to help consumers who should limit their exposure to mercury choose from the many types of fish that are lower in mercury – “including ones commonly found in grocery stores, such as salmon, shrimp, pollock, canned light tuna, tilapia, catfish and cod,” the FDA said in a press release.

However, “it is important to note that women who might become pregnant, or who are pregnant or breastfeeding – along with young children – should avoid the few types of commercial fish with the highest levels of mercury listed on the chart,” FDA said.

Read the full story at Seafood Source

Cell-based seafood faces labeling fight in US

June 3, 2019 — Those who remember the introduction of surimi to the U.S. in the early 1980s might still recall a fight that rose to the federal level involving what it would officially be named.

“Sea Legs,” “King Krab,” “Crab Shapes,” and “crab sticks” were all put forward as options. Eventually, the U.S. Food and Drug Administration required – but did not have the manpower to enforce – the term “imitation crab.” Finally, it agreed in 2006 to the long-winded “Crab-flavored seafood, made with surimi, a fully cooked fish protein.”

Previously, the U.S. government oversaw a protracted fight by the dairy industry against “oleomargarine.” The fight involved questions over classification of the product for tax purposes and a mishmash of state laws, some of which included a requirement to sell margarine in its original pale grey color – the yellow dye to be physically mixed in by the consumer – to avoid deception.

Now the scene is playing out for cell-based meats, if that is what they will finally be called.

“Cell-based meat,” “cell-cultured meat,” or “lab-grown meat,” are all terms referring to artificially cultured muscle or organ cells of animals. The Good Food Institute (GFI), which lobbies for and promotes the plant-based meat analog and cell-based meat industries, promotes the term “clean meat.”

“Rather than obtaining meat from animals raised on environmentally destructive factory farms and slaughtered in filthy slaughterhouses, clean meat is produced by taking a small sample of animal cells and replicating them in a culture outside of the animal. The resulting product is 100 percent real meat, but without the antibiotics, E. coli, salmonella, or waste contamination – all of which come standard in conventional meat production,” the organization explains on its website.

Read the full story at Seafood Source

Trump’s signature gives 26% boost to imported seafood inspections

February 19, 2019 — Don’t be surprised to see more scrutiny by the US Food and Drug Administration (FDA) of imported seafood over the next few months thanks to the inclusion of Senate language in the final fiscal year 2019 appropriations bills signed by president Donald Trump on Friday.

The legislation retains language earlier argued for by Louisiana Republican senators John Kennedy and William Cassidy that requires FDA spend at least $15 million on its inspections of imported seafood during the fiscal year, a $3.1m, or 26%, increase over fiscal 2018.

The US government’s fiscal year ends on Sept. 30, meaning the impact could be felt shortly.

The Senate voted, 83-16, on Thursday afternoon to approve a legislative package that included seven spending measures, and the House followed suit with a 300-128 vote later in the evening. Trump’s signature on Friday ended the months-long budget standoff tied to his efforts to secure funding for a wall on the southern border, though a battle now is expected to begin over his much-reported national emergency declaration.

Read the full story at Undercurrent News

Agreement to end government shutdown brings relief to US seafood industry

January 28, 2019 — Workers at NOAA Fisheries and other federal agencies returned to their jobs Monday, 28 January, for the first time in more than a month, thanks to an agreement reached Friday between the U.S. Congress and the administration of President Donald Trump.

However, the resumption could be short-lived, as the deal to fund several government agencies lasts for only three weeks. That means another shutdown could happen next month if lawmakers and President Trump cannot finalize spending priorities for the 2019 fiscal year or approve another temporary bill.

While the talks hinge on whether the president gets funding for a border wall, numerous other policies and initiatives have been affected by the impasse. That includes some tied to the seafood industry.

For example, while the Food and Drug Administration maintained inspecting foreign seafood imports during the shutdown, funding for additional inspections remains in limbo.

Last July, the Senate passed a bill that would add more than USD 3 million (EUR 2.6 million) in funding for such inspections. However, the House failed to pass the bill, which would increase inspection funding by 26 percent, before Congress’ term ended at the beginning of this month.

Since the new Congress convened, the House has passed a bill that includes the funding, first proposed by U.S. Sen. John Kennedy (R-Louisiana). That bill has yet to pass in the Senate.

Read the full story at Seafood Source